COMMUNIQUÉS West-GlobeNewswire

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
15/10/2026
CONSHOHOCKEN, Pa., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
LB Pharmaceuticals to Participate in Upcoming Investor Events
15/10/2026
NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026
15/10/2026
SALT LAKE CITY, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its third quarter 2026 earnings conference call at 4: [...]
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
15/10/2026
CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, [...]
Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026
15/10/2026
AUSTIN, Texas, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that [...]
LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
15/10/2026
SCOTTSDALE, Ariz., Oct. 15, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental healthcare, will issue its third quarter 2026 earnings [...]
Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026
15/10/2026
BRISBANE, Calif., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Freenome, Inc. (Nasdaq: FRNM), an early cancer detection company developing blood-based screening tests, today announced that the Company plans to release its [...]
Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors
15/10/2026
Financing involving participation from the CEO and Chief Commercial Officer, supports manufacturing scale-up, regulatory testing and preclinical work toward the Company’s planned FDA 510(k) submission in the first [...]
Paretofit Announces Founder Tobias Burkhardt's Feature in Prime Today on Sustainable Performance for Entrepreneurs
15/10/2026
The cover story explores how the German health sociologist applies evidence-based 80/20 principles to help self-employed professionals and entrepreneurs build sustainable personal health systems. Cologne, Germany, Oct. [...]
Affidea signe un accord en vue d’acquérir deux centres Alliance Medical dans le centre de Londres, accélérant ainsi sa croissance au Royaume-Uni
15/10/2026
LONDRES, 15 oct. 2026 (GLOBE NEWSWIRE) -- Affidea , un prestataire paneuropéen de premier plan, spécialisé dans les cliniques de proximité, les examens diagnostiques de pointe et les services de santé privés spécialisés [...]
Oxford Healthspan Launches Primeadine® GF Spermidine Powder, Expanding Its Gluten-Free Line
15/10/2026
New Mixable Gluten-Free Format Offers a More Flexible Way to Incorporate Spermidine Daily SHERIDAN, Wyo., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Oxford Healthspan today announced the launch of Primeadine® GF Spermidine [...]
VIP Plastic Surgery Designated an Accredited Medical Tourism Institution by South Korea’s Ministry of Justice
15/10/2026
Jeju clinic becomes one of two institutions on the island able to sponsor electronic medical visas for 2026-27 JEJU, South Korea, Oct. 15, 2026 (GLOBE NEWSWIRE) -- VIP Plastic Surgery , a Jeju clinic, has been [...]
SPINEWAY : CHIFFRE D’AFFAIRES À 9 MOIS
15/10/2026
Communiqué de presse / Ecully, le 15 octobre 2026 – 18h CHIFFRE D’AFFAIRES 9 MOIS : 8 M€ Poursuite de la structuration pour optimiser les approvisionnements et contribuer à la stratégie de développement Nomination d’ [...]
Spineway : NINE-MONTH REVENUE
15/10/2026
Press release / Ecully, October 15, 2026 – 6 p.m. NINE-MONTH REVENUE: €8 MILLION Continued structuring to optimize supply and support the growth strategy Appointment of Erwan Martin as Deputy Chief Executive Officer In [...]
Booking Health Announces Medical Records Review, Specialist Second Opinions and Treatment Coordination for Pancreatic Cancer Patients Seeking Care in Germany
15/10/2026
Langenfeld, Germany --, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Booking Health, a medical travel coordination service, announces medical records review, specialist second opinions and full treatment coordination for [...]
Digbi Health Brings Precision Biology Care to All 50 States With 700+ Clinicians and Coaches Through OpenLoop Health and MD Integrations
15/10/2026
More than 300 employers and health plans now offer a unified platform for metabolic, inflammatory, and hormonal care, built on each member’s gut microbiome, genetics, and glucose data, as a fully covered benefit [...]
NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
15/10/2026
In advance of November 10, 2026, GDUFA goal date, all requested changes were classified as “MINOR.” NRx was requested to prepare and submit labels with the proprietary name currently under review by FDA. NRx is [...]
TOMI Environmental Solutions Reports Independent Lab Results Showing SteraMist iHP Is Effective Against Listeria Biofilm, a Leading Cause of Food Recalls
15/10/2026
Listeria dropped from tens of millions of bacteria to undetectable or near-undetectable levels, as TOMI partners with an industry expert to expand in food safety FREDERICK, Md., Oct. 15, 2026 (GLOBE NEWSWIRE) -- TOMI [...]
CytoDyn to Host Investor Webcast
15/10/2026
VANCOUVER, Wash., Oct. 15, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]

Pages